| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,667,645 | 1,791,278 | 1,795,261 | 1,602,136 | | Cost of Revenue |
-
| (1,552,998) | 1,552,998 | 1,311,962 | | | Gross Profit | 1,667,645 | 3,344,276 | 242,263 | 290,174 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,615,496 | 3,271,923 | 271,521 | 243,088 | | Non Recurring |
-
|
-
|
-
| 78,339 | | Others | 5,851 | 5,957 | 5,739 | 5,561 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 42,453 | 66,396 | (34,997) | (36,814) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 46,298 | 66,396 | (34,997) | (36,814) | | Interest Expense | 366 | 1,193 | 2,286 | 2,610 | | Income Before Tax | 45,932 | 65,203 | (37,283) | (39,424) | | Income Tax Expense | 17,272 | 28,198 | (350) | (8,335) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 28,660 | 37,005 | (36,933) | (31,089) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 28,660 | 37,005 | (36,933) | (31,089) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $28,660 | $37,005 | ($36,933) | ($31,089) |
|
0.01% Nasdaq 
Income Statement
